(Q79366828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Distinct subtypes of serous ovarian carcinoma identified by p53 determination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Johan Lundin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Arto Leminen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Pentti Lehtovirta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Ralf Butzow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

504-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Reporting results of cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

P53 mutation does not affect prognosis in ovarian epithelial malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

p53 activity and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Gene expression profiling predicts clinical outcome of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Counting alleles to predict recurrence of early-stage colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

Diverse tumorigenic pathways in ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.034

10.1016/J.YGYNO.2003.08.034

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14675668%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference